Prevalence and risk factors of Barrett's esophagus in Korea

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 6, 2007, Pages 908-912

  Kim, Jeong Hwan ^a   Rhee, Poong Lyul ^a   Lee, Jun Haeng ^a   Lee, Hyuk ^a   Choi, Yong Sung ^a   Son, Hee Jung ^a   Kim, Jae J ^a   Rhee, Jong Chul ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Barrett's esophagus; Columnar lined esophagus; Prevalence; Risk factors; Specialized intestinal metaplasia

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BARRETT ESOPHAGUS; CIGARETTE SMOKING; CONTROLLED STUDY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING; SEX DIFFERENCE;

EID: 34250318989     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04448.x     Document Type: Article

References (41)

1. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996 110 : 614 21.
2. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am. J. Gastroenterol. 2002 97 : 1888 95.
3. Csendes A, Smok G, Burdiles P et al. Prevalence of intestinal metaplasia according to the length of the specialized columnar epithelium lining the distal esophagus in patients with gastroesophageal reflux. Dis. Esophagus. 2003 16 : 24 8.
4. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999 116 : 277 85.
5. Murray L, Watson P, Johnston B, Sloan J, Mainie IM, Gavin A. Risk of adenocarcinoma in Barrett's oesophagus: population based study. BMJ 2003 327 : 534 5.
6. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991 265 : 1287 9.
7. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998 83 : 2049 53.
8. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int. J. Epidemiol. 2000 29 : 645 54.
9. Spechler SJ, Goyal RK. Barrett's esophagus. N. Engl. J. Med. 1986 315 : 362 71.
10. Hongo M. Barrett's oesophagus and carcinoma in Japan [Review]. Aliment. Pharmacol. Ther. 2004 20 (Suppl. 8 50 4.
11. Law S, Wong J. Changing disease burden and management issues for esophageal cancer in the Asia-Pacific region. J. Gastroenterol. Hepatol. 2002 17 : 374 81.
12. Toruner M, Soykan I, Ensari A, Kuzu I, Yurdaydin C, Ozden A. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms. J. Gastroenterol. Hepatol. 2004 19 : 535 40.
13. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990 99 : 918 22.
14. Ronkainen J, Aro P, Storskrubb T et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005 129 : 1825 31.
15. Spechler SJ. Columnar-lined esophagus. Definitions. Chest Surg. Clin. N. Am. 2002 12 : 1 13, vii.
16. Spechler SJ. The columnar-lined esophagus. History, terminology, and clinical issues. Gastroenterol. Clin. North Am. 1997 26 : 455 66.
17. Dent J, Brun J, Fendrick AM et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999 44 (Suppl. 2 S1 16.
18. Carlsson R, Dent J, Bolling-Sternevald E et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand. J. Gastroenterol. 1998 33 : 1023 9.
19. Knight RE, Wells JR, Parrish RS. Esophageal dysmotility as an important co-factor in extraesophageal manifestations of gastroesophageal reflux. Laryngoscope 2000 110 : 1462 6.
20. Kastelik JA, Redington AE, Aziz I et al. Abnormal oesophageal motility in patients with chronic cough. Thorax 2003 58 : 699 702.
21. Hill J, Stuart RC, Fung HK et al. Gastroesophageal reflux, motility disorders, and psychological profiles in the etiology of globus pharyngis. Laryngoscope 1997 107 : 1373 7.
22. McClave SA, Boyce HW Gottfried MR. Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointest. Endosc. 1987 33 : 413 16.
23. Boyce HW. Endoscopic definitions of esophagogastric junction regional anatomy. Gastrointest. Endosc. 2000 51 : 586 92.
24. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999 45 : 172 80.
25. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin. Oncol. 1999 26 (Suppl 15 2 8.
26. Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Farkkila M. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000 61 : 6 13.
27. Malfertheiner P, Lind T, Willich S et al. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study. Gut 2005 54 : 746 51.
28. Bak YT, Jung GM, Yeon JE et al. Validity of the specialized columnar epithelium as a diagnostic criterion of the short segment Barrett's esophagus. Korean J. Intern. Med. 1998 13 : 99 103.
29. Trudgill NJ, Suvarna SK, Kapur KC, Riley SA. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut 1997 41 : 585 9.
30. Jones TF, Sharma P, Daaboul B et al. Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy. Dig. Dis. Sci. 2002 47 : 2108 11.
31. Csendes A, Smok G, Flores N, Rojas J, Quiroz J, Henriquez A. Comparison of clinical, endoscopic and functional findings in patients with intestinal metaplasia at the cardia, carditis and short-segment columnar epithelium of the distal esophagus with and without intestinal metaplasia. Dis. Esophagus. 2000 13 : 61 8.
32. Cho YS, Choi MG, Jeong JJ et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am. J. Gastroenterol. 2005 100 : 747 53.
33. Lee JI, Park H, Jung HY, Rhee PL, Song CW, Choi MG. Prevalence of Barrett's esophagus in an urban Korean population: a multicenter study. J. Gastroenterol. 2003 38 : 23 7.
34. Spechler SJ. Clinical practice. Barrett's esophagus. N. Engl. J. Med. 2002 346 : 836 42.
35. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am. J. Gastroenterol. 1999 94 : 2037 42.
36. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000 119 : 333 8.
37. Jankowski JA, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. Gastroenterology 2002 122 : 588 90.
38. Son JI, Park HJ, Song KS et al. A single center's 30 years' experience of esophageal adenocarcinoma. Korean J. Intern. Med. 2001 16 : 250 3.
39. Sharma P, McQuaid K, Dent J et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004 127 : 310 30.
40. Katz PO. Management of the patient with Barrett's esophagus: a continuing dilemma for the clinician. Rev. Gastroenterol. Disord. 2004 4 : 49 59.
41. Oberg S, Johansson J, Wenner J et al. Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery. Ann. Surg. 2001 234 : 619 26.